Cannabis
A New Cannabis Virus And What This Means For Growers; New Testing Available From Green Leaf Lab
The Hop Latent Viroid (HpLVd), a single-stranded, circular infectious RNA, runs rampant in the hemp and cannabis growing communities. Cannabis infected with HpLVd may or may not manifest any apparent symptoms but understanding what those symptoms can be is important to combat this virus.
HpLVd can cause physical symptoms in Cannabis sativa such as stunted growth, a brittle stem, or noticeable malformation of the leaves. Because cannabis plants grow shorter with smaller leaves and tighter node spacing during infection their buds are also stunted, growing smaller, more spaced out, and with far fewer trichomes. On top of these physical symptoms, a dangerous element is found in its name: Hop Latent Viroid. The virus can remain latent or inactive within infected plants, making it nearly impossible to detect without testing. Overall, these contribute to the invisible problem: a lack of potency. Plants infected with HpLVd may have half the cannabinoid content of their healthy counterparts.
Controlling The Spread Through Testing
Since the discovery of HpLVd in 2017, research has been performed and there are now answers and the ability to test. Green Leaf Lab is delighted to announce that they are now offering HpLVd testing.
The state-of-the-art infrastructure and top-of-the-line testing equipment found at our California analytical laboratory enables us to provide advanced HpLVd screening services to our customers. This allows us to detect even the most asymptomatic samples and alert our customers if they have a HpLVd outbreak amongst their stock.
To learn more about Hop Latent Viroid (HpLVd) in cannabis, best practices in preventing the spread, and how Green Leaf Labs can protect your business and its reputation by identifying potential infections, read this month’s blog on HpLVd and visit our website.
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE4 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis3 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Cannabis4 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Humboldt3 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace